Becker's Healthcare August 13, 2024
CMS will share its first round of negotiated Medicare drug costs on Sept. 1, though two drugmakers are still fighting the negotiations.
Here are 10 things to know about the upcoming announcement:
- The Inflation Reduction Act was signed into law in August 2022, giving Medicare the authority to negotiate with drug companies over the price of certain drugs.
- On Aug. 29, CMS announced the list of 10 Medicare Part D drugs that were selected for price negotiations.
- Drugs on the list treat heart conditions, blood clots, leukemia/lymphoma, diabetes, rheumatoid arthritis and psoriasis.
- The 10 drugs are: Eliquis, Enbrel, Farxiga, Fiasp/NovoLog, Entresto, Imbruvica, Januvia, Jardiance, Stelara and Xarelto.
- The drugmakers involved in negotiations are: Bristol Myers...
Today's Sponsors
Today's Sponsor